Contract development and manufacturing organizations (CDMOs)
are integral to the pharmaceutical value chain, having emerged
as prominent players and trusted business partners in meeting
a growing demand for innovative medicines and adaptable
solutions. Over the past three decades, the CDMO industry
transformed significantly, prompting a recalibration of leadership
requirements. Are existing structures and leadership expertise
equipped to navigate the complexities of the CDMO business
and guide organizations successfully through transformation?
This report explores the current state of leadership within CDMOs,
examining both executive leadership and board levels, and its
implications for organizational success.

See all Member News